Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Planta Med ; 79(2): 123-30, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23307235

RESUMEN

Xylopia laevigata, popularly known as "meiú" and "pindaíba", is a medicinal plant used in the folk medicine of the Brazilian Northeast for several purposes. The chemical constituents of the essential oil from leaves of X. laevigata, collected from wild plants growing at three different sites of the remaining Atlantic forest in Sergipe State (Brazilian Northeast), were analyzed by GC/FID and GC/MS. The effect of the essential oil samples was assessed on tumor cells in culture, as well on tumor growth in vivo. All samples of the essential oil were dominated by sesquiterpene constituents. A total of 44 compounds were identified and quantified. Although some small differences were observed in the chemical composition, the presence of γ-muurolene (0.60-17.99%), δ-cadinene (1.15-13.45%), germacrene B (3.22-7.31%), α-copaene (3.33-5.98%), germacrene D (9.09-60.44%), bicyclogermacrene (7.00-14.63%), and (E)-caryophyllene (5.43-7.98%) were verified as major constituents in all samples of the essential oil. In the in vitro cytotoxic study, the essential oil displayed cytotoxicity to all tumor cell lines tested, with the different samples displaying a similar profile; however, they were not hemolytic or genotoxic. In the in vivo antitumor study, tumor growth inhibition rates were 37.3-42.5%. The treatment with the essential oil did not significantly affect body weight, macroscopy of the organs, or blood leukocyte counts. In conclusion, the essential oil from the leaves of X. laevigata is chemically characterized by the presence of γ-muurolene, δ-cadinene, germacrene B, α-copaene, germacrene D, bicyclogermacrene, and (E)-caryophyllene as major constituents and possesses significant in vitro and in vivo anticancer potential.


Asunto(s)
Aceites Volátiles/química , Aceites Volátiles/farmacología , Xylopia/química , Animales , Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Brasil , Línea Celular Tumoral , Células Cultivadas , Eritrocitos/efectos de los fármacos , Cromatografía de Gases y Espectrometría de Masas , Humanos , Leucocitos Mononucleares/efectos de los fármacos , Masculino , Medicina Tradicional , Ratones , Aceites Volátiles/análisis , Hojas de la Planta/química , Hojas de la Planta/efectos de los fármacos , Aceites de Plantas/análisis , Aceites de Plantas/química , Aceites de Plantas/farmacología , Plantas Medicinales/química , Plantas Medicinales/efectos de los fármacos , Sesquiterpenos Policíclicos , Sarcoma 180/tratamiento farmacológico , Sarcoma 180/patología , Sesquiterpenos/análisis , Sesquiterpenos/farmacología , Sesquiterpenos de Germacrano/farmacología
2.
Planta Med ; 78(5): 409-14, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-22274812

RESUMEN

Guatteria friesiana (W. A. Rodrigues) Erkens & Maas (synonym Guatteriopsis friesiana W. A. Rodrigues), popularly known as "envireira", is a medicinal plant found in the Brazilian and Colombian Amazon basin that is used in traditional medicine for various purposes. Recent studies on this species have demonstrated antimicrobial activity. In this study, the antitumor activity of the essential oil from the leaves of G. friesiana (EOGF) and its main components ( α-, ß-, and γ-eudesmol) were determined using experimental models. In the in vitro study, EOGF and its components α-, ß-, and γ-eudesmol displayed cytotoxicity against tumor cell lines, showing IC50 values in the range of 1.7 to 9.4 µg/mL in the HCT-8 and HL-60 cell lines for EOGF, 5.7 to 19.4 µg/mL in the HL-60 and MDA-MB-435 cell lines for α-eudesmol, 24.1 to > 25 µg/mL in the SF-295 and MDA-MB-435 cell lines for ß-eudesmol, and 7.1 to 20.6 µg/mL in the SF-295 and MDA-MB-435 cell lines for γ-eudesmol, respectively. In the in vivo study, the antitumor effect of EOGF was evaluated in mice inoculated with sarcoma 180 tumor cells. Tumor growth inhibition rates were 43.4-54.2 % and 6.6-42.8 % for the EOGF treatment by intraperitoneal (50 and 100 mg/kg/day) and oral (100 and 200 mg/kg/day) administration, respectively. The treatment with EOGF did not significantly affect body mass, macroscopy of the organs, or blood leukocyte counts. Based on these results, we can conclude that EOGF possesses significant antitumor activity and has only low systemic toxicity. These effects could be assigned to its components α-, ß-, and γ-eudesmol.


Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Guatteria/química , Aceites Volátiles/administración & dosificación , Aceites de Plantas/administración & dosificación , Administración Oral , Animales , Antineoplásicos Fitogénicos/uso terapéutico , Brasil , Línea Celular Tumoral , Colombia , Humanos , Concentración 50 Inhibidora , Inyecciones Intraperitoneales , Masculino , Ratones , Estructura Molecular , Aceites Volátiles/uso terapéutico , Hojas de la Planta/química , Aceites de Plantas/uso terapéutico , Plantas Medicinales/química , Sarcoma 180 , Sesquiterpenos de Eudesmano/administración & dosificación , Sesquiterpenos de Eudesmano/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA